- Home
- ADAP vs NMS Comparison
ADAP vs NMS Comparison
Compare ADAP & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- NMS
- Stock Information
- Founded
- ADAP 2008
- NMS 1993
- Country
- ADAP United Kingdom
- NMS United States
- Employees
- ADAP N/A
- NMS N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- ADAP Health Care
- NMS Finance
- Exchange
- ADAP Nasdaq
- NMS Nasdaq
- Market Cap
- ADAP 75.5M
- NMS 67.0M
- IPO Year
- ADAP 2015
- NMS N/A
- Fundamental
- Price
- ADAP $0.08
- NMS $11.36
- Analyst Decision
- ADAP Hold
- NMS
- Analyst Count
- ADAP 6
- NMS 0
- Target Price
- ADAP $1.02
- NMS N/A
- AVG Volume (30 Days)
- ADAP 18.4M
- NMS 12.0K
- Earning Date
- ADAP 08-11-2025
- NMS 01-01-0001
- Dividend Yield
- ADAP N/A
- NMS 4.11%
- EPS Growth
- ADAP N/A
- NMS N/A
- EPS
- ADAP N/A
- NMS N/A
- Revenue
- ADAP $179,639,000.00
- NMS N/A
- Revenue This Year
- ADAP N/A
- NMS N/A
- Revenue Next Year
- ADAP $38.72
- NMS N/A
- P/E Ratio
- ADAP N/A
- NMS N/A
- Revenue Growth
- ADAP 878.53
- NMS N/A
- 52 Week Low
- ADAP $0.08
- NMS $9.21
- 52 Week High
- ADAP $1.36
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- ADAP 25.83
- NMS 56.05
- Support Level
- ADAP $0.08
- NMS $11.16
- Resistance Level
- ADAP $0.36
- NMS $11.25
- Average True Range (ATR)
- ADAP 0.02
- NMS 0.09
- MACD
- ADAP -0.02
- NMS 0.02
- Stochastic Oscillator
- ADAP 1.38
- NMS 86.36
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.